We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Induced Labor Unassociated With Higher C-section Rates

By HospiMedica International staff writers
Posted on 28 Apr 2015
A new study finds no link between labor induction and rates of C-sections in uncomplicated pregnancies of singleton babies at full term.

Researchers at Thomas Jefferson University (Philadelphia, PA, USA) and the University of Naples Federico II (Italy) combined data from five randomized controlled trials that included 844 women who delivered between 39 and 41 weeks and whose water did not break prior to onset of labor, in order to capture only those women whose inductions were without medical indication (rather than medically necessary). More...
The results showed no increase in the risk of C-section in women who were inducted at 39 weeks, compared to those who were not at least past 40 weeks.

Conversely, the researchers noted several benefits of labor induction at 39 weeks. First, induction was associated with slightly less blood loss than non-induced birth; second, meconium staining—a potentially serious complication present during labor—was also less likely to occur in babies of induced mothers; and third, birth weight was lower in babies that were born by induced labor, but only by 136 grams. The study was published online on April 13, 2015, in the American Journal of Obstetrics & Gynecology.

“Although babies have been delivered for centuries, we are still researching the best and safest methods for the mother and baby,” said lead author professor of obstetrics and gynecology Vincenzo Berghella, MD. “Obstetrics today offers women many more options for pain relief and safe delivery, but we have not studied with proper randomized trials which methods are most appropriate for which situations, and what gestational age is best for mother and baby.”

Women who give birth past their due date (in general 40 weeks) are more likely to have meconium (fecal matter) in the amniotic sac. When this meconium staining occurs, there is an increased risk of infection for both the mother and the baby, and a possibility that the baby will inhale the matter into the lungs, which in some cases can lead to death.

Related Links:

Thomas Jefferson University
University of Naples Federico II



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Steam Sterilizer
AMSCO 400 Series
New
Short Phlebotomy Cart
MSWA-3469-WHT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Researchers have taken a major step toward cuff-free blood pressure monitoring (Photo courtesy of Gwyneth Moe/Boston University)

Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension

Hypertension affects nearly half of all adults in the U.S. and remains the leading cause of cardiovascular disease. Regular and accurate blood pressure monitoring is essential for managing this condition,... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.